Literature DB >> 16596559

Vacutainer filling time through subcutaneous venous access devices.

G A Goossens1, M Vrebos, I De Wever, M Stas.   

Abstract

INTRODUCTION: The functionality of subcutaneous venous access devices is evaluated at least every time the device is accessed. This evaluation is subjective and actions are only undertaken when blood withdrawal and/or fluid injection become problematic. The function of these devices has rarely been evaluated objectively. The present study tried to find an objective and standardized way to evaluate the withdrawal speed of a newly inserted port.
METHODS: Between October 2001 and December 2002, a prospective randomized study of 3 types of ports was carried out. The ability to infuse heparinized normal saline and to withdraw blood was evaluated by recording the filling time of a 10 ml Vacutainer tube in 876 newly inserted central venous ports at the end of the surgical procedure.
RESULTS: The patient groups were comparable in age, gender and insertion procedure characteristics (vein used, position of the port on the body and length of the catheter). The median time needed to fill a 10 ml Vacutainer tube in all ports was 17.00 sec (range 11.43-63.62 sec). The median filling time for BardPort was 16.36 sec (range 13.48-39.00 sec), for Celsite 18.35 sec (range 12.03-40.00 sec) and for Port-a-cath 16.43 sec (range 11.43-63-62 sec). A significant difference in filling time was found between the large bore catheters (BardPort, Port-a-cath) and the small bore catheter (Celsite) of 2 seconds median value.
CONCLUSION: Measurement of withdrawal speed provides an objective criterion for the quality description of blood withdrawal immediately after insertion. A value of more than 20 seconds for filling a 10 ml Vacutainer tube could therefore be suggested a useful trigger for further investigation.

Entities:  

Year:  2004        PMID: 16596559     DOI: 10.1177/112972980400500404

Source DB:  PubMed          Journal:  J Vasc Access        ISSN: 1129-7298            Impact factor:   2.283


  4 in total

1.  A pilot trial of microplasmin in patients with long-term venous access catheter thrombosis.

Authors:  Peter Verhamme; Martine Jerome; Godelieve Goossens; Joanna Devis; Geert Maleux; Marguerite Stas
Journal:  J Thromb Thrombolysis       Date:  2009-02-19       Impact factor: 2.300

2.  A dose-finding clinical trial of staphylokinase SY162 in patients with long-term venous access catheter thrombotic occlusion.

Authors:  Peter Verhamme; Godelieve Goossens; Geert Maleux; Désiré Collen; Marguerite Stas
Journal:  J Thromb Thrombolysis       Date:  2007-02-03       Impact factor: 2.300

3.  Diagnostic accuracy of the Catheter Injection and Aspiration (CINAS) classification for assessing the function of totally implantable venous access devices.

Authors:  G A Goossens; Y De Waele; M Jérôme; S Fieuws; C Janssens; M Stas; P Moons
Journal:  Support Care Cancer       Date:  2015-07-26       Impact factor: 3.603

4.  Functional evaluation of conventional 'Celsite' venous ports versus 'Vortex' ports with a tangential outlet: a prospective randomised pilot study.

Authors:  G A Goossens; G Verbeeck; P Moons; W Sermeus; I De Wever; M Stas
Journal:  Support Care Cancer       Date:  2008-04-15       Impact factor: 3.603

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.